Your browser doesn't support javascript.
loading
Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors.
Fizazi, Karim; Drake, Charles G; Beer, Tomasz M; Kwon, Eugene D; Scher, Howard I; Gerritsen, Winald R; Bossi, Alberto; den Eertwegh, Alfons J M van; Krainer, Michael; Houede, Nadine; Santos, Ricardo; Mahammedi, Hakim; Ng, Siobhan; Danielli, Riccardo; Franke, Fabio A; Sundar, Santhanam; Agarwal, Neeraj; Bergman, André M; Ciuleanu, Tudor E; Korbenfeld, Ernesto; Sengeløv, Lisa; Hansen, Steinbjorn; McHenry, M Brent; Chen, Allen; Logothetis, Christopher.
Affiliation
  • Fizazi K; Gustave Roussy, University of Paris Sud, Villejuif, France. Electronic address: karim.fizazi@gustaveroussy.fr.
  • Drake CG; Columbia University Herbert Irving Comprehensive Cancer Center, New York, NY, USA.
  • Beer TM; Oregon Health & Science University Knight Cancer Institute, Portland, OR, USA.
  • Kwon ED; Mayo Clinic, Rochester, MN, USA.
  • Scher HI; Memorial Sloan-Kettering Cancer Center, New York, NY, USA; Weill-Cornell Medical College, New York, NY, USA.
  • Gerritsen WR; Radboud University Nijmegen Medical Centre, Nijmegen, The Netherlands.
  • Bossi A; Institut Gustave Roussy, Villejuif, France.
  • den Eertwegh AJMV; VU University Medical Center, Amsterdam, The Netherlands.
  • Krainer M; Vienna General Hospital (AKH Wien), Wien, Austria.
  • Houede N; CHU of Nimes, Nimes, France; Montpellier University, Montpellier, France.
  • Santos R; Centro Médico Austral, Buenos Aires, Argentina.
  • Mahammedi H; Centre Jean Perrin, Clermont-Ferrand, France.
  • Ng S; St John Of God Hospital, Subiaco, Australia.
  • Danielli R; University Hospital of Siena, Istituto Toscano Tumori, Siena, Italy.
  • Franke FA; Hospital de Caridade de Ijuí, Ijuí, Brazil.
  • Sundar S; Nottingham University Hospitals NHS Trust, Nottingham, UK.
  • Agarwal N; Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
  • Bergman AM; The Netherlands Cancer Institute and Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.
  • Ciuleanu TE; Institute of Oncology Ion Chiricuta, Cluj-Napoca, Romania.
  • Korbenfeld E; Hospital Britanico de Buenos Aires, Buenos Aires, Argentina.
  • Sengeløv L; Herlev Hospital, Region Hovedstadens Apotek, Herlev, Denmark.
  • Hansen S; Odense University Hospital, Odense, Denmark.
  • McHenry MB; Bristol-Myers Squibb Company, Wallingford, CT, USA.
  • Chen A; Bristol-Myers Squibb Company, Wallingford, CT, USA.
  • Logothetis C; The University of Texas M. D. Anderson Cancer Center, Houston, TX, USA.
Eur Urol ; 78(6): 822-830, 2020 12.
Article in En | MEDLINE | ID: mdl-32811715
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Ipilimumab / Antineoplastic Agents, Immunological Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Eur Urol Year: 2020 Document type: Article Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prostatic Neoplasms, Castration-Resistant / Ipilimumab / Antineoplastic Agents, Immunological Type of study: Clinical_trials / Prognostic_studies Limits: Aged / Humans / Male / Middle aged Language: En Journal: Eur Urol Year: 2020 Document type: Article Country of publication: